ID

44575

Beschreibung

Effects of Dapagliflozin on the Incretin Sensitivity of the Pancreatic Beta Cell; ODM derived from: https://clinicaltrials.gov/show/NCT02420392

Link

https://clinicaltrials.gov/show/NCT02420392

Stichworte

Versionen (2)
  1. 21.03.19 21.03.19 -
  2. 27.09.21 27.09.21 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

27. September 2021

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diabetes Mellitus, Type 2 NCT02420392

Englisch

Eligibility Diabetes Mellitus, Type 2 NCT02420392

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes for dapagliflozin arm
Beschreibung

Diabetes Mellitus, Non-Insulin-Dependent | Dapagliflozin Protocol Treatment Arm

Datentyp

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2,1]
C2353951
UMLS CUI [2,2]
C1522541
normal glucose tolerance (fasting plasma glucose <100 mgd/l, hba1c <6.0%) for normal glucose tolerance arm
Beschreibung

Glucose tolerance test normal | Plasma fasting glucose measurement | Hemoglobin A1c measurement | Glucose tolerance normal Protocol Treatment Arm

Datentyp

boolean

Alias
UMLS CUI [1]
C0438251
UMLS CUI [2]
C0583513
UMLS CUI [3]
C0474680
UMLS CUI [4,1]
C0438251
UMLS CUI [4,2]
C1522541
age 18 to 75 years
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
bmi <35 kg/m2
Beschreibung

Body mass index

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
for type 2 diabetes patients, at least 3 months of treatment period and hba1c 7.5 to 11.0% and treatment with lifestyle modification and/or metformin or sulfonylurea
Beschreibung

Diabetes Mellitus, Non-Insulin-Dependent | Hemoglobin A1c measurement | Lifestyle change therapy | Metformin | Sulfonylurea

Datentyp

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0474680
UMLS CUI [3]
C2960841
UMLS CUI [4]
C0025598
UMLS CUI [5]
C0038766
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
who is allergic to dapagliflozin
Beschreibung

Hypersensitivity Dapagliflozin

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C2353951
type 1 diabetes
Beschreibung

Diabetes Mellitus, Insulin-Dependent

Datentyp

boolean

Alias
UMLS CUI [1]
C0011854
patients with history of diabetic ketoacidosis
Beschreibung

Diabetic Ketoacidosis

Datentyp

boolean

Alias
UMLS CUI [1]
C0011880
reduced renal function (egfr <60ml/min/1.73m2)
Beschreibung

Renal Insufficiency | Estimated Glomerular Filtration Rate

Datentyp

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C3811844
taking loop diuretics or dehydrated patient
Beschreibung

Loop Diuretics | Patient Dehydrated

Datentyp

boolean

Alias
UMLS CUI [1]
C0354100
UMLS CUI [2,1]
C0030705
UMLS CUI [2,2]
C0011175
history of hypotension when taking hypertensive medication
Beschreibung

Hypotension | Relationship Antihypertensive Agents

Datentyp

boolean

Alias
UMLS CUI [1]
C0020649
UMLS CUI [2,1]
C0439849
UMLS CUI [2,2]
C0003364
diagnosed with heart failure
Beschreibung

Heart failure

Datentyp

boolean

Alias
UMLS CUI [1]
C0018801
diagnosed with cerebral infarction
Beschreibung

Cerebral Infarction

Datentyp

boolean

Alias
UMLS CUI [1]
C0007785
taking insulin, dpp-4 inhibitor, glp-1 analogue, pioglitazone, alpha-glucosidase inhibitor
Beschreibung

Insulin | DPP-4 Inhibitor | GLP-1 Analogue | pioglitazone | alpha-Glucosidase Inhibitors

Datentyp

boolean

Alias
UMLS CUI [1]
C0021641
UMLS CUI [2]
C3537225
UMLS CUI [3]
C3273809
UMLS CUI [4]
C0071097
UMLS CUI [5]
C1299007
above upper limit of normal hematocrit range (male 39-52%, female 36-48%)
Beschreibung

Hematocrit increased | Gender

Datentyp

boolean

Alias
UMLS CUI [1]
C0239935
UMLS CUI [2]
C0079399
pregnant or breastfeeding women
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
history of recurrent genitourinary infection
Beschreibung

Genitourinary tract infection Recurrent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1279264
UMLS CUI [1,2]
C2945760
ast/alt more than two fold increased above normal upper limit
Beschreibung

Aspartate aminotransferase increased | Alanine aminotransferase increased

Datentyp

boolean

Alias
UMLS CUI [1]
C0151904
UMLS CUI [2]
C0151905
hemolytic disorder
Beschreibung

Hemolytic disorder

Datentyp

boolean

Alias
UMLS CUI [1]
C1263988
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Diabetes Mellitus, Type 2 NCT02420392

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent | Dapagliflozin Protocol Treatment Arm
Item
type 2 diabetes for dapagliflozin arm
boolean
C0011860 (UMLS CUI [1])
C2353951 (UMLS CUI [2,1])
C1522541 (UMLS CUI [2,2])
Glucose tolerance test normal | Plasma fasting glucose measurement | Hemoglobin A1c measurement | Glucose tolerance normal Protocol Treatment Arm
Item
normal glucose tolerance (fasting plasma glucose <100 mgd/l, hba1c <6.0%) for normal glucose tolerance arm
boolean
C0438251 (UMLS CUI [1])
C0583513 (UMLS CUI [2])
C0474680 (UMLS CUI [3])
C0438251 (UMLS CUI [4,1])
C1522541 (UMLS CUI [4,2])
Age
Item
age 18 to 75 years
boolean
C0001779 (UMLS CUI [1])
Body mass index
Item
bmi <35 kg/m2
boolean
C1305855 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent | Hemoglobin A1c measurement | Lifestyle change therapy | Metformin | Sulfonylurea
Item
for type 2 diabetes patients, at least 3 months of treatment period and hba1c 7.5 to 11.0% and treatment with lifestyle modification and/or metformin or sulfonylurea
boolean
C0011860 (UMLS CUI [1])
C0474680 (UMLS CUI [2])
C2960841 (UMLS CUI [3])
C0025598 (UMLS CUI [4])
C0038766 (UMLS CUI [5])
Item Group
C0680251 (UMLS CUI)
Hypersensitivity Dapagliflozin
Item
who is allergic to dapagliflozin
boolean
C0020517 (UMLS CUI [1,1])
C2353951 (UMLS CUI [1,2])
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Diabetic Ketoacidosis
Item
patients with history of diabetic ketoacidosis
boolean
C0011880 (UMLS CUI [1])
Renal Insufficiency | Estimated Glomerular Filtration Rate
Item
reduced renal function (egfr <60ml/min/1.73m2)
boolean
C1565489 (UMLS CUI [1])
C3811844 (UMLS CUI [2])
Loop Diuretics | Patient Dehydrated
Item
taking loop diuretics or dehydrated patient
boolean
C0354100 (UMLS CUI [1])
C0030705 (UMLS CUI [2,1])
C0011175 (UMLS CUI [2,2])
Hypotension | Relationship Antihypertensive Agents
Item
history of hypotension when taking hypertensive medication
boolean
C0020649 (UMLS CUI [1])
C0439849 (UMLS CUI [2,1])
C0003364 (UMLS CUI [2,2])
Heart failure
Item
diagnosed with heart failure
boolean
C0018801 (UMLS CUI [1])
Cerebral Infarction
Item
diagnosed with cerebral infarction
boolean
C0007785 (UMLS CUI [1])
Insulin | DPP-4 Inhibitor | GLP-1 Analogue | pioglitazone | alpha-Glucosidase Inhibitors
Item
taking insulin, dpp-4 inhibitor, glp-1 analogue, pioglitazone, alpha-glucosidase inhibitor
boolean
C0021641 (UMLS CUI [1])
C3537225 (UMLS CUI [2])
C3273809 (UMLS CUI [3])
C0071097 (UMLS CUI [4])
C1299007 (UMLS CUI [5])
Hematocrit increased | Gender
Item
above upper limit of normal hematocrit range (male 39-52%, female 36-48%)
boolean
C0239935 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
pregnant or breastfeeding women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Genitourinary tract infection Recurrent
Item
history of recurrent genitourinary infection
boolean
C1279264 (UMLS CUI [1,1])
C2945760 (UMLS CUI [1,2])
Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
ast/alt more than two fold increased above normal upper limit
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
Hemolytic disorder
Item
hemolytic disorder
boolean
C1263988 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video